A person who survives a bleeding stroke may continue to face danger years after leaving the hospital. New research indicates that more intensive treatment of high blood pressure could substantially lower the chance of having another stroke.
The research focused on intracerebral hemorrhage, a severe stroke caused by bleeding inside the brain. Unlike the more common ischemic stroke, which happens when a clot blocks blood flow, an ICH begins when a blood vessel breaks.
Blood that escapes into the brain can injure nearby tissue and create dangerous pressure. Although emergency treatment has improved, ICH still has a high risk of death and disability, and survivors can experience another stroke later.
Blood pressure is a major target for prevention because long-term hypertension damages the walls of small arteries. If those vessels become weak, they may rupture and cause another brain hemorrhage.
To better understand how much blood pressure should be lowered after ICH, researchers brought together individual results from four randomized clinical trials. Altogether, the analysis included 2,944 adults with a history of brain hemorrhage.
Some trials used particular blood pressure drug combinations, while others treated patients toward specific blood pressure goals. This allowed the researchers to study the overall effect of more intensive treatment rather than focusing on just one medicine.
Over follow-up periods extending to six years, another stroke occurred in 6.5% of people receiving intensive blood pressure treatment. The rate was 10.4% among people receiving standard care or less intensive treatment.
In practical terms, the intensive approach was linked to a 38% reduction in the risk of another stroke. Professor Craig Anderson and colleagues estimated that treating 1,000 ICH survivors more intensively could prevent around 16 recurrent strokes in the first year.
Most of the improvement came from preventing another hemorrhagic stroke. The risk of another ICH was about 61% lower among people receiving intensive blood pressure treatment.
The difference in achieved blood pressure was meaningful but not enormous. During follow-up, average systolic blood pressure was about 127 mm Hg in the intensive group and about 138 mm Hg in the comparison group.
Systolic pressure is the first or top number shown in a blood pressure reading. It measures pressure in the arteries when the heart contracts and pushes blood forward.
A major concern with stronger blood pressure treatment is whether lowering pressure too much could cause other problems. Older people in particular may experience dizziness, falls or reduced blood flow to important organs when treatment is not carefully adjusted.
Reassuringly, the new analysis did not find more serious adverse events with intensive treatment. Such events were reported in roughly 29% of intensively treated participants and 33% of people receiving standard or less intensive care.
Another striking finding involved patients who entered the studies with systolic blood pressure already at 130 mm Hg or below. Even in this group, 13.9% of control participants had another stroke, compared with 6.2% receiving more intensive treatment.
This challenges the idea that reaching a standard target automatically means the remaining risk is small. It suggests that doctors may need to consider a patient’s history of brain hemorrhage, rather than relying only on whether a blood pressure reading falls below a general guideline threshold.
The research was published in The Lancet Neurology in 2026. The meta-analysis included four randomized trials, including the TRIDENT trial led by The George Institute for Global Health, which specifically recruited people with spontaneous intracerebral hemorrhage.
The findings could matter worldwide. More than 3 million people experience an ICH each year, and millions of survivors continue living with a heightened risk of stroke and cardiovascular disease.
The problem is particularly serious in low- and middle-income countries, where ICH rates are higher and many people with hypertension do not achieve reliable blood pressure control. Affordable combination pills and clear treatment plans could make intensive control easier to maintain in these settings.
The study is persuasive because it combines randomized evidence rather than relying only on ordinary medical records. Its consistent results across different trials, starting blood pressure levels and times since the original stroke strengthen the argument that the association is real.
Still, the findings need to be applied carefully. A meta-analysis can show the average effect across thousands of patients, but an individual person’s safest blood pressure goal may depend on age, frailty, kidney function, other diseases and the medicines they take.
The research therefore supports more active blood pressure management rather than self-treatment or a universal target for everyone. For ICH survivors, regular monitoring, taking prescribed medicines consistently and working with clinicians to reach a safe, stable pressure may be one of the most effective ways to reduce the chance of another devastating stroke.
If you care about stroke, please read studies that diets high in flavonoids could help reduce stroke risk, and MIND diet could slow down cognitive decline after stroke.
For more health information, please see recent studies about antioxidants that could help reduce the risk of dementia, and tea and coffee may help lower your risk of stroke, dementia.
Source: The George Institute for Global Health.
